Aconitase Detection and Activity Profiling for Metabolic Research

Comprehensive Aconitase Detection and Activity Profiling for Metabolic Research, Disease Biomarker Studies, and Biopharmaceutical Quality Control

Aconitase (aconitate hydratase, EC 4.2.1.3) is a crucial mitochondrial and cytosolic enzyme that catalyses the reversible stereospecific isomerisation of citrate to isocitrate via the intermediate cis-aconitate in the tricarboxylic acid (TCA) cycle. Beyond its primary metabolic function, aconitase plays a central role in iron homeostasis, oxidative stress response, and the regulation of cellular energy metabolism. The enzyme exists in two isoforms: mitochondrial aconitase (ACO2), which is a key component of the TCA cycle, and cytosolic aconitase (ACO1), which functions as an iron-responsive element-binding protein (IRE-BP) that post-transcriptionally regulates the expression of ferritin and transferrin receptor. Dysregulation of aconitase activity is strongly associated with neurodegenerative diseases (e.g., Friedreich's ataxia, Parkinson's disease), metabolic disorders (e.g., diabetes, obesity), and various cancers, making it a significant biomarker and therapeutic target. The accurate and comprehensive characterisation of aconitase—encompassing enzymatic activity, protein abundance, iron‑sulfur cluster integrity, isoform discrimination, and sensitivity to oxidative stress—is essential for understanding disease mechanisms, evaluating drug effects, and ensuring the quality of biological products. Our specialised detection platform offers a fully validated suite of biochemical, mass spectrometric, and functional assays tailored to aconitase from mammalian, microbial, and recombinant sources, delivering the high‑precision, regulatory‑ready data that clients require for research, diagnostics, and biopharmaceutical quality control.

Scientific and Clinical Rationale for Aconitase Analysis

Clients seeking aconitase detection services are motivated by a range of strategic objectives. In metabolic and mitochondrial research, the primary need is to quantify aconitase activity and protein levels in tissues and cells to assess TCA cycle flux, evaluate mitochondrial function, and investigate the effects of metabolic perturbations. In oxidative stress and iron metabolism studies, measuring the activity of aconitase (which is highly sensitive to oxidant-induced inactivation due to its [4Fe-4S] cluster) provides a direct readout of cellular oxidative damage and iron status. In drug discovery and pharmacology, evaluating the effect of candidate compounds on aconitase activity is critical for identifying modulators of energy metabolism and for assessing off‑target toxicity. In clinical diagnostics and biomarker development, quantifying aconitase activity in blood, cerebrospinal fluid, or tissue biopsies supports the diagnosis and monitoring of neurodegenerative and metabolic disorders. In quality control of biological reagents, verifying the activity and integrity of recombinant or purified aconitase preparations is essential for ensuring their reliability in research and diagnostic applications. In regulatory submissions, comprehensive data on enzyme activity, stability, and purity are required for the approval of novel therapeutics and diagnostic kits. Our service is architected to address these diverse needs with a flexible, ISO 17025‑accredited analytical framework that adapts to the specific isoform, sample matrix, and client's research or regulatory context.

Integrated Analytical Platform for Holistic Aconitase Characterisation

Our analytical platform comprises four interconnected modules that collectively deliver a comprehensive evaluation of aconitase quality and performance. The Activity Quantification Module employs a range of validated assays, including the continuous spectrophotometric assay monitoring the formation of isocitrate (or the disappearance of citrate) coupled to isocitrate dehydrogenase, and the cis-aconitate hydratase activity assay using a colorimetric or fluorometric substrate. We determine the specific activity (U/mg protein) with precision within ±2% RSD and a limit of detection (LOD) as low as 0.001 U/mL. For detailed kinetic characterisation, we calculate Michaelis‑Menten parameters (K_m for citrate, V_max, k_cat) and inhibition constants for known inhibitors (e.g., oxalomalate, nitrosuccinate), with 95% confidence intervals typically within ±5%. The Isoform and Iron‑Sulfur Cluster Module uses native PAGE and size‑exclusion chromatography (SEC‑HPLC) to resolve cytosolic (ACO1) and mitochondrial (ACO2) isoforms, and to assess the integrity of the [4Fe‑4S] cluster by measuring the activity recovery after reconstitution with ferrous iron and sulfide. For absolute quantitation and isoform discrimination, we use LC‑MS/MS‑based targeted proteomics (PRM) with stable isotope‑labelled peptide standards, achieving LOQs in the low fmol/mg range and enabling the simultaneous quantitation of both isoforms in a single run. The Protein Quantitation Module uses ELISA with isoform‑specific antibodies (e.g., anti‑ACO1, anti‑ACO2) to quantify protein abundance, providing LOQs of 0.05 ng/mg of total protein and inter‑assay precision < 5%. The Oxidative Stress and Stability Module assesses the enzyme's sensitivity to oxidants (e.g., hydrogen peroxide, nitric oxide) and the effect of antioxidant treatments, and evaluates its stability under various storage conditions (temperature, pH, freeze‑thaw). Using Arrhenius modelling and deactivation kinetics, we predict shelf‑life and identify critical degradation pathways (e.g., cluster disassembly, deamidation). All modules are validated with reference aconitase standards (recombinant or purified from natural sources) and include rigorous quality controls (system suitability, blank subtraction, and replicate analyses).

Unmatched Analytical Sensitivity, Specificity, and Mechanistic Insight

Our platform consistently delivers performance that surpasses typical industry and academic standards. In activity assays, we achieve signal‑to‑noise ratios > 300:1 at the LOD, with linearity over four orders of magnitude and Z’‑factors consistently > 0.8, making our assays highly robust for high‑throughput screening. Our kinetic fitting software uses global non‑linear regression to provide precise estimates of K_m and V_max, with residual errors < 2%. For protein quantitation by PRM, our chromatographic gradient resolves isoform‑specific peptides with retention time reproducibility < 0.5% RSD and peak area precision < 3%. In iron‑sulfur cluster assessment, we use electron paramagnetic resonance (EPR) spectroscopy to directly detect the [4Fe‑4S]²⁺ cluster and to monitor its oxidation state, providing a definitive measure of enzyme integrity that complements activity data. Additionally, we offer isothermal titration calorimetry (ITC) to measure the binding affinity of inhibitors, providing ΔH, ΔS, and binding stoichiometry with precision within ±2%. For clients requiring detailed structural insight, we perform hydrogen‑deuterium exchange mass spectrometry (HDX‑MS) to map conformational changes induced by substrate binding or oxidant stress. This multi‑dimensional data set enables our clients to not only quantify enzyme activity but also to understand the molecular basis of its regulation, inactivation, and function, facilitating the rational design of therapeutic strategies and diagnostic tools.

Distinctive Advantages of Our Aconitase Detection Service

Our service provides several unique benefits that directly address client challenges. First, we have developed matrix‑specific sample preparation protocols for a wide variety of aconitase sources—including tissue homogenates, cell lysates, clinical biopsies, and purified recombinant proteins—that effectively preserve enzyme activity and protein integrity (especially the labile iron‑sulfur cluster), achieving recoveries > 95% for all tested matrices. Second, we maintain a comprehensive reference library of aconitase isoforms and their characterised kinetic, inhibition, and stability data, enabling rapid method setup and confident benchmarking. Third, we offer a rapid screening service using a microplate‑based activity assay that provides semi‑quantitative activity data within 1 hour of sample receipt—ideal for high‑throughput screening of compound libraries or patient cohorts. Fourth, our customised oxidative stress simulation studies can expose aconitase to controlled oxidant conditions while monitoring activity and cluster integrity, providing data that directly inform the evaluation of antioxidant therapies and oxidative stress biomarkers. Fifth, we provide integrated data interpretation that links aconitase activity, isoform abundance, and cluster integrity to biological or clinical outcomes (e.g., disease severity, drug efficacy), enabling clients to make informed decisions on candidate selection and patient stratification. Sixth, all our methods comply with ICH M10, FDA, and EMA guidelines on bioanalytical method validation, and we supply full validation dossiers (specificity, linearity, accuracy, precision, LOD, LOQ, robustness) along with detailed SOPs, ensuring that our data are readily accepted by regulatory authorities. Our team of enzymologists, mitochondrial biologists, and clinical researchers provides consultative interpretation, helping clients to design follow‑up experiments, predict in vivo efficacy, and support regulatory submissions.

Advanced Data Integration, Predictive Modeling, and Reporting

Our reporting transforms analytical data into strategic decision‑making knowledge. We deliver a comprehensive final report that includes: (i) an executive dashboard with key metrics (specific activity, K_m, isoform ratio, cluster integrity score, and inhibitor IC₅₀) presented as concise scorecards; (ii) a detailed analytical section containing raw data, calibration curves, kinetic fits, and EPR spectra; (iii) a statistical comparison of samples against reference standards or historical data, with p‑values and confidence intervals; and (iv) an interpretive narrative that contextualises the results—for example, explaining how a low specific activity with normal protein abundance indicates oxidative inactivation, or how a shift in the ACO1/ACO2 ratio may reflect metabolic reprogramming. For clients with multiple compounds or patient cohorts, we provide multivariate analysis (PCA, PLS‑DA) to identify the most influential parameters and to guide selection. We also offer predictive models that estimate disease progression or therapeutic response based on in vitro aconitase activity data, using our internally developed machine learning tools. All raw data files (e.g., .xlsx, .raw, .cdf) are supplied to ensure full transparency and re‑analysis capability.

Broad Applications Across Drug Discovery, Clinical Diagnostics, and Mitochondrial Research

The versatility of our aconitase detection service spans a wide range of sectors. In pharmaceutical and biotech R&D, our assays are critical for target validation, lead optimisation, and toxicity profiling of metabolism‑modulating compounds. In clinical diagnostics, we quantify aconitase activity and protein levels in patient samples to support the diagnosis and monitoring of neurodegenerative diseases, metabolic syndromes, and mitochondrial disorders. In nutritional and oxidative stress research, we evaluate the impact of antioxidants and dietary components on aconitase function. In biopharmaceutical quality control, our methods detect aconitase as a process‑related impurity in cell‑derived products. In academic research, our comprehensive profiling supports publication‑quality studies on enzyme regulation, iron metabolism, and redox biology. In contract research organisations (CROs), our services provide robust data to support regulatory submissions. Our ability to tailor the analytical package to the specific isoform, sample type, and regulatory framework ensures that we serve a diverse global clientele with scientific rigour and practical relevance.

Commitment to Innovation, Quality, and Client Partnership

We are dedicated to advancing aconitase analytics through continuous technological improvement. Our current R&D includes the development of microfluidic‑based single‑cell activity assays for ultra‑sensitive detection, and the application of machine learning algorithms to predict enzyme stability from sequence and structural features. We actively participate in inter‑laboratory proficiency testing for enzyme activity and protein analysis, and we contribute to the development of reference standards for iron‑sulfur cluster‑containing enzymes. Our quality management system is ISO 9001 and ISO 17025 certified, and we follow GLP for all regulatory studies. We offer flexible engagement models—from single‑sample analysis to multi‑year collaborative projects—with dedicated project managers, volume discounts, and priority handling for time‑sensitive samples. Our global logistics provide specialised shipping kits (with stabilising buffers and temperature control) to preserve enzyme activity during transit. Turnaround times range from 1 business day for rapid screening to 12 business days for comprehensive kinetic, proteomic, and cluster‑integrity profiling. We maintain open communication, providing preliminary results upon request and final reports with expert commentary. Our success is measured by the confidence our clients have in their data and their ability to advance research, drug development, and clinical care. We invite you to partner with us to unlock the full potential of your aconitase research.

In summary, our aconitase detection service delivers a comprehensive, precise, and application‑oriented analytical solution that integrates activity quantification, isoform discrimination, iron‑sulfur cluster integrity assessment, and inhibitor screening. By combining advanced instrumentation with deep expertise in metabolic enzymology and redox biology, we empower our clients to accelerate drug discovery, understand mitochondrial dysfunction, and improve diagnostic accuracy. We look forward to supporting your aconitase analysis needs with our state‑of‑the‑art analytical platform.